Related references
Note: Only part of the references are listed.3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
Timothy J. Iveson et al.
LANCET ONCOLOGY (2018)
Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
Lawrence Lee et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
Junichi Nishimura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Burcin Baran et al.
GASTROENTEROLOGY RESEARCH (2018)
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis
Yu Guo et al.
CANCER INVESTIGATION (2016)
Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection
Ko-Chao Lee et al.
ONCOTARGETS AND THERAPY (2016)
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
Dimitrios Pectasides et al.
BMC CANCER (2015)
Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
R. Baird et al.
BRITISH JOURNAL OF CANCER (2011)
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
G. Rosati et al.
ANNALS OF ONCOLOGY (2010)
Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?
D. J. Storey et al.
ANNALS OF ONCOLOGY (2010)
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
Fatima Haggar et al.
Clinics in Colon and Rectal Surgery (2009)
Systemic treatment of colorectal cancer
Brian M. Wolpin et al.
GASTROENTEROLOGY (2008)
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: A final report of the AIO colorectal study group
Rainer Porschen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
J Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
